Εμφανίζονται 1 - 20 Αποτελέσματα από 79 για την αναζήτηση '"доброкачественная гиперплазия простаты"', χρόνος αναζήτησης: 0,76δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    Συγγραφείς: Sevryukov F.A.

    Συνεισφορές: 1

    Πηγή: Annals of the Russian academy of medical sciences; Vol 78, No 1 (2023); 62-76 ; Вестник Российской академии медицинских наук; Vol 78, No 1 (2023); 62-76 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn.781

    Περιγραφή αρχείου: application/pdf

  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
    Academic Journal

    Συγγραφείς: I. I. Belousov, И. И. Белоусов

    Πηγή: Urology Herald; Том 6, № 4 (2018); 5-12 ; Вестник урологии; Том 6, № 4 (2018); 5-12 ; 2308-6424 ; 10.21886/2308-6424-2018-6-4

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.urovest.ru/jour/article/view/230/182; Deering RE, Bigler SA, King J. Choongkittaworn M, Aramburu E, Brawer MK. Morphometric quantitation of stroma in human benign prostatic hyperplasia. Urology. 1994;44(1):64-70. PMID: 7518983; Levin RM, Monson FC, Haugaard N, Buttyan R, Hudson A, Roelofs M, Sartore S, Wein AJ. Genetic and cellular characteris tics of bladder outlet obstruction. Urol. Clin. North Am. 1995;22(2):263-283. PMID: 7762110; Глыбочко П.В., Аляев Ю.Г., Маркосян Т.Г., Никитин С.С., Григорян В.А., Арзуманян Э.Г. Роль функционального состояния мышц тазового дна и кортико спинального тракта в нарушениях мочеиспускания при заболеваниях простаты. Урология. 2011;3:18-22.; Taylor BC, Wilt TJ, Fink HA, Marshall LM, Hoff man AR, Beer TM, Bauer DC, Zmuda JM, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Study Research Group. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: The MrOS study. Urology. 2006;68(4):804-809. DOI:10.1016/j.urology.2006.04.019; Almeida FG, Freitas DG, Bruschini H. Is the ultrasoundes timated bladder weight a reliable method for evaluating bladder outlet obstruction? BJU Int. 2011;108(6):864-867. DOI:10.1111/j.1464-410X.2010.09881.x; Xu D, Cui X, Qu C, Yin L, Wang C, Chen J. Urodynamic pattern distribution among aged male patients with lower urinary tract symptoms suggestive of bladder outlet obstruc tion. Urology. 2014;83(3);563-569. DOI:10.1016/j.urology.2013.10.033; Sagnier PP, Macfarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level bother and quality of life of men in the French community. J Urol. 1995;153(3 pt 1):669-673. PMID: 7532230; AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol. 2003;170(2 Pt 1):530-547. DOI:10.1097/01.ju.0000078083.38675.79; Лоран О.Б., Вишневский Е.Л., Кан Я.Д., Халимов З.М. Причины сохранения расстройств мочеиспускания после аденомэктомии. Тезисы Всероссийского пленума научн. общества урологов. Курск. 1993:117.; D‘Silva KA, Dahm P, Wong CL. Does this man with lower urinary tract symptoms have bladder outlet obstruction?: The Rational Clinical Examination: a systematic review. JAMA. 2014;312(5):535-542. DOI:10.1001/jama.2014.5555; Kogan M, Belousov I. Clinical value of function urethral sphincter for surgical treatment BPH. “Improving Research for Common Future”. 3rd Scientifi c Symposium. Medical Faculty of the University of Cologne. Köln 2003. Аbstr. 75.; Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J; International Scientifi c Committee. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2009;181(4):1779-1787. DOI:10.1016/j.juro.2008.11.127; Nitti VW. Appropriate workup for lower urinary tract symptoms in men. Can Urol Assoc J. 2012;6(5 Suppl 2):S141-142. DOI:10.5489/cuaj.12204; Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N’dow J, Nordling J, de la Rosette JJ; European Association of Urology. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118-140. DOI:10.1016/j.eururo.2013.03.004; Kang M, Kim M, Choo MS, Bae J, Ku JH, Yoo C, Oh SJ. Associa tion of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Urology. 2014;84(6):1461-1466. DOI:10.1016/j.urology.2014.08.037; Bulut S, Ozden C, Aktas BK, Deren T, Tagci S, Gokkaya CS, Baykam MM, Memis A. Eff ects of medical therapy or surgery on prostatic and bladder resistive indices in patients with Benign Prostatic Hyperplasia. Urol Int. 2015;94(2):181-186. DOI:10.1159/000363581; Tubaro A, Carter S, Hind A, Vicentini C, Miano L. A prospective study of the safety and effi cacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol. 2001;166(1):172-176. PMID: 11435849; Roehrborn CG, McConnell JD, Barry MJ, et al. AUA Guideline on the Management of Benign Prostatic Hyperplasia. Linthicum, MD: American Urological Association Education and Research, Inc.; 2006.; Lee Y-S, Lee HN, Han J-Y, Choo M-S, Lee I-S. Most bothersome symptom and symptom specifi c goal achievement in patients with BPO: a prospective open label study. J Urol. 2011;185(3):1003-1009. DOI:10.1016/j.juro.2010.10.085; Steers WD, BarrettDM, Wein AJ. Voiding dysfunction: Diagnosis, classifi cation, and management. In Gillenwater JY, Grayhack JT, Howards SS, DuckettJWJr. eds. Adult and Pediatric Urology. Chicago. Year Book Medical Publishers. 1996:1220-1326.; Suhani, Gupta S, Gupta A, Saha S, Mahapatra L, Srivastava U. Outcome of surgery for benign prostatic hyperplasia is it predictable? J Clin Diagn Res. 2013;7(12):2859-2862. DOI:10.7860/JCDR/2013/7606.3888; Cox L, Jaffe WI. Urodynamics in Male LUTS. Urol Clin North Am. 2014;41(3):399-407. DOI:10.1016/j.ucl.2014.04.009; DuBeau CE, Sullivan MP, Cravalho E, Resnick NM, Yalla SV. Correlation between micturitional urethral pressure profile and pressure-flow criteria in bladder outlet obstruction. J. Urol. 1995;154(2 Pt 1):498-503. PMID: 7541866; Roehrborn CG. Focus on Lower Urinary Tract Symptoms: Nomenclature, Diagnosis, and Treatment Options. Highlights from the 5th International Consultation on Benign Prostatic Hyperplasia, June 25–27, 2000, Paris, France. Rev Urol. 2001;3(3):139-145. PMID: 16985706; Fang Q, Song B, Li W, Lu G, Jin X, Zhang X, Fan R. Role of UPP in evaluating bladder outlet obstruction due to benign prosta tic enlargement. Neurourol Urodyn. 2007;26(6);842-846. PMID 17565728; Litwin MS, McNaughton-Collins M, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA, Alexander RB, Farrar JT, O’Leary MP. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J. Urol. 1999;162(2):369-375. PMID: 10411041; Abrams P, Cardozo L, Fall M, Griffi ths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A; Standardisation Sub-committee of the International Continence Society. The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167-178. PMID: 11857671; Пат. 2250748 Рос. Федерация, МПК А 61 Р 13/08. Способ лечения доброкачественной гиперплазии простаты / Белоусов И.И., Коган М.И.; заявитель и патентообладатель Белоусов И.И., Коган М.И. – № 2003115152/14; заявл. 21.05.03; опубл. 27.04.05, Бюл. № 12. – 9 с. Доступно по: http://bd.patent.su/2250000-2250999/pat/ servl/servlet7f12.html Ссылка активна на 29.10.2018.; Mundy AR, Thomas PJ. Clinical physiology of the bladder, urethra and pelvic fl oor. Urol. Clin. North Am. 1993;18:450-481.; https://www.urovest.ru/jour/article/view/230

  11. 11
  12. 12
  13. 13
    Academic Journal

    Πηγή: Urology Herald; № 3 (2015); 54-67 ; Вестник урологии; № 3 (2015); 54-67 ; 2308-6424 ; 10.21886/2308-6424-2015-0-3

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.urovest.ru/jour/article/view/19/21; Jeong CW, Park YH, Ku JH, Kwak C, Kim HH. Minimally invasive management of postoperative bleeding after radical prostatectomy: transarterial embolization. J Endourol. 2010 Sep;24(9):1529-33.; Prostatic arterial embolization to treat benign prostatic hyperplasia / J. М. Pisco, L. C. Pinheiro, Т. Bilhim [et al.] // J. Vasc. Interv. Radiol. — 2011. — Jan. — Vol. 22 (1). — Р. 11–9.; Эмболизация артерий предстательной железы в лечении больных аденомой предстательной железы с высоким хирургическим риском / Е. А. Яковец, А. И. Неймарк, А. А. Карпенко, Я. В. Яковец // Андрология и генитальная хи- рургия. — 2010. — № 1. — С. 38–43.; Carnevale FC, Motta Leal Filho JM, Antunes AA, Cerri LM, Baroni RH, Marcelino AZ, et al. Quality of life and symptoms relief support prostatic artery embolization for patients with acute urinary retention due to benign prostatic hyperplasia. J of Vascular and Interventional Radiology. 2012;23(3):S4.; Pisco J.M., Rio Tinto H, Campos Pinheiro L, Bilhim T, Duarte M, Fernandes L, Pereira J, Oliveira AG. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. EurRadiol. 2013 Sep;23(9):2573-4.; Gao YA, Huang Y, Zhang R, Yang YD, Zhang Q, Hou M, Wang Y. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial. Radiology. 2014;270(3):920-8.; Bruix J. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution / J. Bruix, J.M. Llovet, A. Castells // Hepatology. - 1998. -Vol.27. - N6. -P.578-579.; Di Stefano D.R. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients / D.R. Di Stefano, T. de Baere, A. Denys // Radiology. - 2005. - Vol.234. - P.625-630.; Hallisey M.J. Angiographic embolization for the control of massive postpartum and gynecologic hemorrhage / M.J. Hallisey, W. Miller, S.K. Sussman // Radiology. - 1994. - Vol.193. - P.299-308.; Johansson M. Clinical outcome after endovascular coil embolization in elderly patients with subarachnoid hemorrhage / M. Johansson, O. Norback, G. Gal //Neuroradiology. - 2004. - Vol.46. - P.385-391.; https://www.urovest.ru/jour/article/view/19

  14. 14
  15. 15
  16. 16
    Academic Journal

    Συγγραφείς: O. Y. Hublarov, О. Ю. Хубларов

    Πηγή: Urology Herald; № 2 (2014); 25-40 ; Вестник урологии; № 2 (2014); 25-40 ; 2308-6424 ; 10.21886/2308-6424-2014-0-2

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.urovest.ru/jour/article/view/56/59; Mebust, W.K. Transurethral prostatectomy: immediate and postoperative complications: a cooperative study of 13 participating institutions evaluating 3,885 patients / W.K. Mebust, H.L. Holtgrewe, A.T. Cockett, P.C. Peters // J Urol. – 1989. – Vol.141 – P.243-247.; Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia / N.P. Roos, J.E. Wennberg, D.J. Malenka et al. // N Engl J Med – 1989. – Vol.320 – P.1120-1124.; Adverse events after prostatectomy in Victorian public hospitals / M.Z. Ansari, A.J. Costello, D.J. Jolley et al. // Aust N Z J Surg – 1998. – Vol.68. – P.830-836.; Holtgrewe, H.L. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2,015 cases. / H.L. Holtgrewe, W.L. Valk // J Urol – 1962. – Vol.87. – P.450-459.; Combination holmium and Nd: YAG laser ablation of the prostate: initial clinical experience. / P.J. Gilling, C.B. Cass, A.R. Malcolm, M.R. Fraundorfer // J Endourol – 1995. – Vol.9. – P.151-153.; Technical Aspects of Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia / M. Kim, H. Lee, S. Oh // Korean J Urol. – 2013. – Sep., Vol.54, №9. –P.570-579.; Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia / P.J. Gilling, C.B. Cass, M.D. Cresswell, M.R. Fraundorfer // Urology – 1996. – Vol.47. – P.48-51.; Moody, J.A. Holmium laser enucleation for prostate adenoma greater than 100 gm: comparison to open prostatectomy / J.A. Moody, J.E. Lingeman // J Urol – 2001. – Vol.165. – P.459-462.; Tan, A.H. Holmium laser prostatectomy: current techniques / A.H. Tan, P.J. Gilling // Urology. – 2002. – Vol.60 – P.152-156.; Complications of laser prostatectomy: a review of recent data / M. Rieken, N. Ebinger Mundorff, G. Bonkat et al. // World J Urol – 2010. – Vol.28. – P.53- 62.; Elzayat, E.A. Holmium laser enucleation of the prostate (HoLEP): longterm results, reoperation rate, and possible impact of the learning curve / E.A. Elzayat, M.M. Elhilali // Eur Urol – 2007. – Vol.52. – P.1465-1471.; Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review / A. Descazeaud, G. Robert, A.R. Azzousi AR et al.// BJU Int – 2009. – Vol.103 – P.1162-1165.; Holmium laser enucleation of the prostate (HoLEP): a technical update / R.L. Kuo, R.F. Paterson, S.C. Kim et al. // World J Surg Oncol. – 2003. – Vol.1. – P.6.; Peri-operative complications of holmium laser enucleation of the pros-tate: experience in the first 280 patients, and a review of literature / H.N. Frah, A.P. Mahajan, S.S. Hegde, M.B. Bansal // BJU Int. – 2007. – Vol.100. – P.94-101.; Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 grams: a randomized trial / T.F. Aho, P.J. Gilling, K.M. Kennett et al. // J Urol. – 2005. – Vol.174.– P.210-214.; Gilling, P.J. Holmium laser enucleation of the prostate for glands larger than 100 g: an endourologic alternative to open prostatectomy / P.J. Gilling, K.M. Kennett, M.R. Fraundorfer // J Endourol – 2000. – Vol.14. – P.529-531.; Elzayat, E.A. Holmium laser enucleation of the prostate: a size-independent new «gold standard» / E.A. Elzayat, E.I. Habib, M.M. Elhilali // Urology – 2005. – Vol.66, 5 Suppl. – P.108-113.; A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years / L.C. Wilson, P.J. Gilling, A. Williams et al. // Eur Urol. – 2006. – Vol.50. – P.569-573.; Prospective evaluation of the learning curve for holmium laser enucleation of the prostate / H.N. Frah, A.P. Mahajan, H.S. Sodha et al. // J Urol. – 2007. – Vol.177. – P.1468-1474.; Fraundorfer, M.R. Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results / M.R. Fraundorfer, P.J. Gilling // Eur Urol – 1998. – Vol.33. – P.69-72.; Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia / F. Montorsi, R. Naspro, A. Salonia et al. // J Urol – 2008. –Vol.179, 5 Suppl. – P.87-90.; Holmium laser enucleation of the prostate combined with electrocautery resection: the muFrroom technique / W.W. Hochreiter, G.N. Thalmann, F.C. Burkhard, U.E. Studer // J Urol. – 2002. – Vol.168(4 Pt 1). – P.1470-1474.; El-Hakim, A. Holmium laser enucleation of the prostate can be taught: the first learning experience / A. El-Hakim, M.M. Elhilali // BJU Int – 2002. – Vol.90. – P.863-869.; https://www.urovest.ru/jour/article/view/56

  17. 17
    Academic Journal

    Πηγή: Acta Biomedica Scientifica; № 5 (2014); 38-43 ; 2587-9596 ; 2541-9420

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.actabiomedica.ru/jour/article/view/1809/1756; Аполлхин О.И., Сивков А.В., Бешлиев Д.А., Солнцева Т.В. и др. Анализ урологической заболеваемости в Российской Федерации в 2002-2009 годах по данным официальной статистики // Эксперим. клин. урология. - 2011. - № 1. - С. 4-10; Белостоцкая Л.И., Гомон О.Н., Никитченко Ю.В., Чайка Л.А. и др. Прооксидантно-антиоксидантный баланс в предстательной железе и крови крыс при индуцированной сульпиридом гиперплазии простаты и коррекции простатиленом // Бюл. эксперим. биол. и мед. - 2005. - Т. 139, № 3. - С. 313-315; Боровская Т.Г., Фомина Т.И., Ермолаева Л.А., Вычужанина А.В. и др. Сравнительная оценка эффективности простатотропных средств природного происхождения при экспериментальной доброкачественной гиперплазии предстательной железы // Бюл. эксперим. биол. и мед. - 2013. - № 1. - С. 73-77; Волков А.А., Воронова О.В., Петричко М.И., Будник Н.В. и др. Морфологические изменения в простате под влиянием терапии дутастеридом // Фундаментальные исследования. - 2012. - № 12, Ч. 1. - С. 36-39; Кудрявцев Ю.В., Сивков А.В. Морфологические изменения в ткани предстательной железы при доброкачественной гиперплазии // Эксперим. клин. урология. - 2010. - № 1. - С. 18-22; Павлов В.Н., Казихинуров А.А., Измайлов А.А. Пути оптимизации медикаментозного лечения больных с доброкачественной гиперплазией предстательной железы // Бюл. сиб. мед. - 2012. - Т. 11, № 2. - С. 133-138; Плотников М.Б., Чернышова Г.А., Смольякова В.И., Краснов Е.А. и др. Антиоксидантные и кардиопротекторные свойства п-тирозола при ишемии миокарда с реперфузией у крыс // Кардиология. - 2010. - № 11. - С. 47-49; Чайка А.В., Бородин А.Д., Черноус В.А., Вербовой П.П. Применение комплексного препарата «Алимакс» в лечении доброкачественной гиперплазии предстательной железы // Медико-социальные проблемы семьи. - 2012. - Т. 17, № 1. - С. 80-84; Ходченкова И.П., Зарубина И.В., Шабанов П.Д. Метаболические изменения в предстательной железе и иммунный статус крыс при доброкачественной гиперплазии // Психофармакология и биол. наркология. - 2005. - Т. 5, № 4. - С. 1091-1085; Coppenolle V F., Slomianny C., Carpentier F. et al. Effect of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence // Am. J. Physiol. Endocrinol. Metab. - 2001. - Vol. 280, N 1. - P. 120-129; Fujimoto N., Sueoka N., Sueoka E. et al. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1 // Int. J. Oncol. - 2002. - N 20. - Р. 1233-1239.; Gupta S., Hussain T., Mukhtar H. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells // Arch. Biochem. Biophys. - 2003. - N 410 (1). - Р. 177-185.; Marks L.S., Epstein J.I., Partin A.B., Simon I. et al. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia // J. Urol. - 2000. - Vol. 163. - P. 1451-1456.; Muller C.H., Lee T.K.Y., Montano M.A. Improved chemiluminescence assay for measuring antioxidant capacity of seminal plasma // In: Spermatogenesis. Methods and Protocols; ed. by L. Barnard, K.I. Aston. - 2012. - Vol. 927. - Р. 363-376.; https://www.actabiomedica.ru/jour/article/view/1809

  18. 18
  19. 19
  20. 20